Three researchers at Jefferson have recently been awarded significant grants from area foundations that will further the development of new treatments for cancer and vascular disease. A grant from The W.W. Smith Charitable Trust bolsters the research of Alain Mauviel, PhD; Adam P. Dicker, MD, PhD, has received support for his scientific studies from The Mary L. Smith Charitable Lead Trust; and James D. San Antonio, PhD, has been awarded a Margaret Q. Landenberger Research Foundation grant to conduct his investigations.
The W.W. Smith Charitable Trust, based in Newtown Square, has granted $122,000 over a two-year period to fund the work of Dr. Alain Mauviel, Associate Professor of Dermatology and Cutaneous Biology. His research focuses on preventing malignant tumors from spreading from one organ to another. Dr. Mauviel's studies are expected to advance scientific understanding of the processes that underlie tumor progression and metastasis.
The Mary L. Smith Charitable Lead Trust, also in Newtown Square, has awarded a one-year grant of $60,000 to strengthen the research studies of Adam Dicker, MD, PhD, Assistant Professor of Radiation Oncology. The grant will support his investigation into how the genetic composition of a malignant tumor affects response to chemotherapy and sensitivity to radiation. The results of Dr. Dicker's studies are expected to lead to new, more effective treatments for nonresponsive cancerous tumors.
The Philadelphia-based Margaret Q. Landenberger Research Foundation has awarded a one-year grant of $30,000 to Jefferson for Dr. James San Antonio's research into the drug heparin and its use in the fight against vascular disease. Some patients have a resistance to heparin and are thus denied its potential beneficial effects. Dr. San Antonio, who is an Assistant Professor of Medicine at Jefferson, will focus his research on ways to identify heparin-resistant cells and understand their role in vascular diseases. ( Visit our website at http://www.tju.edu/jeffgiving/ )